# A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572

> **NCT00858455** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 16 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** GSK1349572 and MaaloxAdvanced Maximum Strength
- **DRUG:** GSK1349572 and Maalox Advanced Maximum Strength
- **DRUG:** GSK1349572 and One A Day
- **DRUG:** GSK1349572

## Key facts

- **NCT ID:** NCT00858455
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2009-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858455, "A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00858455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*